VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 225 filers reported holding VERACYTE INC in Q4 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,370,575 | +64.4% | 106,161 | +87.5% | 0.06% | +55.3% |
| Q2 2023 | $1,442,086 | -49.7% | 56,619 | -56.0% | 0.04% | -51.9% |
| Q1 2023 | $2,867,936 | +24.9% | 128,607 | +32.9% | 0.08% | +21.5% |
| Q4 2022 | $2,296,400 | +127.8% | 96,772 | +59.3% | 0.06% | +85.7% |
| Q3 2022 | $1,008,000 | +16.0% | 60,752 | +242.1% | 0.04% | -62.0% |
| Q4 2020 | $869,000 | +122.3% | 17,760 | +47.5% | 0.09% | +268.0% |
| Q3 2020 | $391,000 | +83.6% | 12,039 | +35.6% | 0.02% | +38.9% |
| Q3 2019 | $213,000 | -68.4% | 8,878 | -62.4% | 0.02% | -70.5% |
| Q2 2019 | $673,000 | +307.9% | 23,607 | +79.8% | 0.06% | +510.0% |
| Q4 2018 | $165,000 | +10.7% | 13,132 | -15.9% | 0.01% | -9.1% |
| Q3 2018 | $149,000 | -32.3% | 15,621 | -37.6% | 0.01% | -80.0% |
| Q3 2017 | $220,000 | -52.9% | 25,030 | -50.8% | 0.06% | -8.3% |
| Q1 2017 | $467,000 | +190.1% | 50,865 | +145.0% | 0.06% | +140.0% |
| Q4 2016 | $161,000 | – | 20,765 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |